Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan for Diastolic Dysfunction in Hypertensive Patients
NCT01691118Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Sep 2012
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fimasartan in hypertension (HTN), diastolic dysfunction, heart failure with preserved ejection fraction (HFpEF), sponsored by Asan Medical Center. Started Sep 2012; status: completed.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)diastolic dysfunctionheart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01691118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691118.